Arthrosis (osteoarthritis) is one of the most common rheumatic disorders in the United States. Contrary to popular belief, it doesn't only occur among the elderly, young people can also suffer from this obstructive disorder. Research has shown that cannabis is a safe and effective treatment for this condition.
Osteoarthritis is characterized by painful (and sometimes inflamed) joints, due to the deteriorated quality of cartilage in the musculoskeletal system.
The cartilage cushions that prevent bones from rubbing against each other deteriorate in quality. Become softer and thinner, causing the bone under the cartilage to deform and visible and palpable nodules (osteophytes) to form.
These lumps not only limit the flexibility of the joint, they can also pinch nerves, resulting in pain, sensory disorders. Loss of strength.
Because we use our joints constantly, holding a cup, writing, typing, opening a tap, tying laces. Bending down for example – osteoarthritis can be very limiting for patients. It's estimated that about 80 percent of all atrose patients are somehow limited in their mobility. Ironically, regular exercise and maintaining a healthy weight can actually slow down the progress of osteoarthritis.
Patients often get a prescription for painkillers or are advised to use NSAIDs – such as ibuprofen – against the symptoms of their disease. However, in the long term, these can be harmful to the stomach and cause fatal gastric bleeding. Moreover, these drugs aren't always effective but are very expensive to buy.
Cannabis often turns out to be a more effective and safer alternative to these harmful substances. Some doctors are firmly convinced of this and even recommend exchanging NSAIDs such as ibuprofen for cannabis. After all, the most common active cannabinoids in weed, THC. CBD, appear to be enormously potent anti-inflammatory drugs.
It's even thought that cannabidiol (CBD) is a more potent anti-inflammatory than pharmaceuticals. In addition, delta-9-tetrahydrocannabinol (THC) has been shown in several studies to be a strong painkiller. Osteoarthritis patients, therefore, benefit from both CBD and THC, in the form of cannabis oil for example.
A study on animal models confirms the potential of cannabis as a drug against osteoarthritis. The stimulation of CB2 receptors in the backbone of rats(1) led to a decrease in pain response and inflammation. Researchers found among other things that animals with osteoarthritis, :
Stimulating the CB2 receptors with (in this case synthetic) cannabinoids yielded the following results:
According to the researchers, ‘stimulating CB2 receptors can offer therapeutic benefits in the treatment of (osteoarthritis) pain’. CB2-receptors can be stimulated with the body’s own cannabinoids, vegetable cannabinoids (from weed). Synthetic forms of these plant substances, as was done in the research in question. However, our preference remains for the natural form of cannabidiol, from hemp or the cannabis plant, as a diluted CBD oil. Example.
Cannabinoid therapies provide, according to scientists, ‘a neurobiological basis for the analgesic effects of the CB2 receptor’. By doing so, they want to make it clear that the analgesic effects of cannabis don't stem from the regulation of emotions. From an actual physiological reaction.
In conclusion, the scientists draw three conclusions from this research. Since (1) opiate painkillers are only an option for osteoarthritis patients for whom standard treatments are ineffective or should be avoided. (2) the use of opiates can lead to undesirable side effects such as addiction and death. (3) cannabis can potentially partially or completely replace opiates in some cases, patients can greatly benefit from the availability of safe painkillers such as cannabinoids.
BETHESDA, Md.--(BUSINESS WIRE)--At the launch of the autumn flu season and amid a rash of…
ARLINGTON, Va.--(BUSINESS WIRE)--The Medical Device Innovation Consortium (MDIC) Board of Directors has established the inaugural…
TORONTO & NEW YORK--(BUSINESS WIRE)--The conventional yearly medical checkup is due for a redesign. New…
BOSTON--(BUSINESS WIRE)--Amwell® (NYSE: AMWL), a digital care delivery leader, today announced the continued expansion of…
BOSTON--(BUSINESS WIRE)--Working with CEOs of primary care associations across the country, the National Association of…
Guidehouse, a leading global provider of consulting services to the public and commercial markets, has…